The four components dont all point to the same mechanism
To date, no direct comparisons between the two peptides exist, leaving us to rely only on available data from their respective clinical trials
BPC-157 and TB-500 can be injected at any time
Eli Lilly and Companys next-generation injectable (retatrutide) is showing even greater weight loss and blood sugar reductions than todays GLP-1s, with ~1517% weight loss in diabetes patients and prior data approaching ~25%+ in obesitypotentially the most effective therapy weve seen to date
Liver Nutrients provides a synergistic blend of milk thistle, NAC, alpha-lipoic acid, and other nutrients that support Phase 1 and Phase 2 liver detoxification, glutathione production, and liver cell regenerationtake 2 capsules daily with food
A key differentiator of CT-388 lies in its design to produce potent activity on both the GLP-1 and GIP receptors, along with minimal-to-no -arrestin recruitment on either receptor